IGF2BP1 and neuroblastoma: IGF2BP proteins have been reported to influence the sensitivity of chemotherapeutics, as for instance demonstrated in neuroblastoma cell lines, where IGF2BP1 promotes resistance towards doxorubicin (Bell et al., 2015).